Zydus Cadila gets American health regulator's approval to market mineral supplement

Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market Potassium Chloride extended release tablets in the strengths of 10 mEq (750 mg) and 20 mEq (1,500 mg), Zydus Cadila, part of Cadila Healthcare group.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3ktZbx3
via IFTTT